| 发明名称 |
Compositions and methods for pharmacogenomic screening of CYP2C9 and VKORC1 |
| 摘要 |
Compositions and methods for determining an optimal dose of a medication for a subject are described that include determining the subject's genotype for the CYP2C9 and VKORC1 genes and determining the dose of the medication based on the genotype. Articles of manufacture also are provided that include polynucleotides for genotyping.
|
| 申请公布号 |
US2011097713(A1) |
申请公布日期 |
2011.04.28 |
| 申请号 |
US20090583539 |
申请日期 |
2009.08.21 |
| 申请人 |
CATALYST ASSETS LLC |
发明人 |
BRIGGS THOMAS;JOHNSON JAMES R.;PRIDGEN JEREMY C.;MURPHY MICHAEL P.;PHILLIPS SUZANNE L.;NAKHLE PAMELA J. |
| 分类号 |
C12Q1/68;C07H21/00 |
主分类号 |
C12Q1/68 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
